Kristina Allan Recognized as the Best Real Estate Agent in Lake Las Vegas, NV With Top 1% Nevada Status, 48 Closings and $25.2M+ Sold in 24 Months, and "Triple-Threat" Realtor + Appraiser + Mortgage Loan Officer Expertise
Read More
Kim V. Colaprete of Team Diva Real Estate Recognized as the Best Realtor in Capitol Hill, Seattle for Top-4% Global Coldwell Banker Team Performance, 700+ Career Transactions, and "Diva Dwellings" + "DivaLux" Listing Strategy
Read More
This broadcast airs as sponsored programming and includes television commercials from NeOnc Technologies (NASDAQ:NTHI), Synergy CHC (NASDAQ:SNYR), DataVault AI (NASDAQ:DVLT), and The Sustainable Green Team (OTCQB:SGTM).
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time anomaly detection, and longitudinal observability, paired with transparent, audit-ready reporting and responsible AI use with clear human accountability.
Read More
Headlined by Bert Kreischer, Lynyrd Skynyrd, Diplo, & ERNEST, Full Throttle Festival Reveals Immersive On-Site Activations & Fan Experiences Ahead of February 14 Event
Read More
Company to unveil its rebranding and offering for Defense and Security markets, its 2026 roadmap, and offering for an autonomous system of combat-proven systems unified under one operational domain
At the Airshow, Ondas will present its concept and multi layered solution addressing one of the most complicated challenges of modern defense: protecting critical assets from threats operating at the low-altitude and ground domains.
Read More
N-trans-caffeoyltyramine (NCT) is an interesting naturally occurring compound that has attracted scientific attention in exploratory studies related to lipid metabolism and energy utilization pathways.
The production was executed by an external partner under pilot-scale conditions using standardized protocols.
The pilot run achieved approximately 99% reaction conversion, 90% isolated yield, and 535 grams of NCT at 99.6% pharma-grade purity.
Reaction performance was observed to improve at increased operating scale.
High-purity NCT now available for formulation development with commercial partners.
Moderna will continue to lead clinical development and manufacturing for mRNA-3927
Moderna to receive up to $160 million in upfront and near-term development and regulatory milestones, in addition to commercial and sales milestones and tiered royalties on net sales
Read More